519 studies found for:    (pregnancy OR maternal) AND (acquired immunodeficiency syndrome)
Show Display Options
RSS Create an RSS feed from your search for:
(pregnancy OR maternal) AND (acquired immunodeficiency syndrome)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Anti-HIV Immune Serum Globulin (Human);   Drug: Globulin, Immune;   Drug: Zidovudine
2 Terminated Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Maternal and infant nevirapine;   Drug: Maternal placebo and infant nevirapine;   Drug: Maternal lopinavir+ritonavir;   Drug: zidovudine
3 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
4 Completed Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: HIV immune globulin solution
5 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
6 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
7 Completed Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: sulfadoxine-pyrimethamine intermittent preventive treatment;   Drug: chloroquine
8 Recruiting Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
9 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
10 Completed Mentor Mothers: A Sustainable Family Intervention in South African Townships
Conditions: Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome;   Tuberculosis
Intervention: Behavioral: Peer support and mentoring
11 Not yet recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
12 Completed Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: ZDV Short (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Short (mother)-Long (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Long (infant): Comparison of zidovudine durations
13 Active, not recruiting Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
14 Completed A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine
15 Completed Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Lamivudine;   Drug: Lamivudine/Zidovudine;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Zidovudine
16 Completed Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Ritonavir;   Drug: Saquinavir;   Drug: Lamivudine;   Drug: Zidovudine
17 Completed Daily Nevirapine to Prevent Mother to Infant Transmission of HIV
Condition: HIV Infections
Intervention: Drug: Nevirapine and mulitvitamins
18 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
19 Completed A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine
20 Completed A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: Nevirapine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years